Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or

Akari Therapeutics (AKTX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Akari Therapeutics 75/76 WIMPOLE STREE LONDON X0 W1G 9RT GBR

P: 44-20-8004-0270

Description:

Akari Therapeutics PLC is a biopharmaceutical company. It focused on the development and commercialization of innovative therapeutics to treat orphan autoimmune and inflammatory diseases. The Company's lead drug consist of Coversin is a recombinant small protein, which acts on complement component-C5, preventing release of C5a and formation of C5b-9. Akari Therapeutics PLC, formerly known as Celsus Therapeutics Plc, is based in London, United Kingdom.

Key Statistics

Overview:

Market Capitalization, $K 37,105
Shares Outstanding, K 15,857
Annual Sales, $ 0 K
Annual Net Income, $ -16,470 K
60-Month Beta -3.75
% of Insider Shareholders 61.80%
% of Institutional Shareholders 14.69%
Float, K 6,057
% Float 38.20%

Growth:

1-Year Return 27.07%
3-Year Return -83.91%
5-Year Return -95.41%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 90.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Next Earnings Date 04/03/19
Earnings Per Share ttm -0.35
EPS Growth vs. Prev Qtr 25.00%
EPS Growth vs. Prev Year 57.14%
Annual Dividend Rate, $ 0.00
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00
Most Recent Split 1-10 on 09/17/15

AKTX Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward -1.67
Price/Earnings to Growth N/A
Return-on-Equity (After Tax) -227.51
Return-on-Assets (Before Tax) -123.56
Profit Margin % N/A
Net Margin % N/A
Debt/Equity 0.00
Price/Sales N/A
Price/Cash Flow N/A
Price/Book 12.41
Book Value/Share 0.20
Interest Coverage N/A
Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar